BioSpace News Archive

Pharm Country

Physician Burnout in Small Practices is Dramatically Lower than National Average, New Study Concludes

Findings offer insight into creating better work environments for physicians in larger practices and health systems

July 9, 2018
·
4 min read
DYSIS Medical Raises £18 Million to Accelerate Growth

DYSIS Medical Ltd announces today the completion of an £18 million ($25 million) investment.

July 9, 2018
·
3 min read
Business

Private Label Brands’ Nutripathic line of homeopathic remedies for joint pain, pH acid / alkaline balance, stress and allergies available now on RonnieColemanNutrition.com

Private Label Brands’ Nutripathic line of homeopathic remedies for stress, anxiety, allergies, sinusitis, joint pain and body pH balance are now available on health and wellness e-commerce site RonnieColemanNutrition.com.

July 9, 2018
·
2 min read
Business

Neosanté Health Solutions, creators of Delictase®, on new Royal Children’s Hospital infant colic study

Neosanté Health Solutions discuss a study about the possibility of long-term effects baby colic has into adulthood, and how its unique product can prevent the baby colic from happening in the first place.

July 9, 2018
·
2 min read
Policy

SenzaGen’s Final Validation Report for the Animal-free Allergy Test GARDpotency™ has Been Submitted to the Regulatory Authorities

SenzaGen announces that the company has submitted the official validation report for GARDpotency™ to the relevant regulatory authorities as a complement to the validation of GARDskin™.

July 9, 2018
·
4 min read
Policy

Axonics® Receives CE Mark for its Sacral Neuromodulation External Trial System

Axonics Modulation Technologies, Inc., announced that it has received the CE mark for its Sacral Neuromodulation External Trial System.

July 9, 2018
·
4 min read
BioMidwest

Autism Home Support Services Sponsors First-Ever Sensory Friendly Hours at Taste of Chicago on July 15

Also Provides Quiet Tent and Activities in Chicago Parent’s Kids Eat Section

July 9, 2018
·
1 min read
FDA

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Hepatocellular Carcinoma (HCC)

First Orphan Drug Designation for OBI-3424, a novel first-in-class targeted therapy for solid tumors that express aldo-keto reductase 1c3 (AKR1C3) enzyme

July 9, 2018
·
4 min read
Job Trends

GB Sciences One of Ten Companies Named in Important New Canadian Research Publication

Corporate strategy dedicated to scientific medical research, a viable drug development pipeline and a strong Intellectual Properties Patent Portfolio are cited as the key differentiating factors.

July 9, 2018
·
5 min read
Biotech Beach

Research Highlights The Importance Of Spinal Alignment In All, Not Just Deformity, Lumbar Fusions

Peer-reviewed article validates effectiveness of the NuVasive® Integrated Global Alignment platform

July 9, 2018
·
6 min read